ERG11 mutations and upregulation in clinical itraconazole-resistant isolates of Candida krusei.

about

ERG11 mutations and upregulation in clinical itraconazole-resistant isolates of Candida krusei.

Item

http://www.wikidata.org/entity/Q51512831

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

ERG11 mutations and upregulati ...... nt isolates of Candida krusei.

@en

ERG11 mutations and upregulati ...... nt isolates of Candida krusei.

@nl

type

Item

label

ERG11 mutations and upregulati ...... nt isolates of Candida krusei.

@en

ERG11 mutations and upregulati ...... nt isolates of Candida krusei.

@nl

prefLabel

ERG11 mutations and upregulati ...... nt isolates of Candida krusei.

@en

ERG11 mutations and upregulati ...... nt isolates of Candida krusei.

@nl

P1476

ERG11 mutations and upregulati ...... nt isolates of Candida krusei.

@en

P2093

Jing Yang

http://www.w3.org/2001/XMLSchema#string

Jinyu Chen

http://www.w3.org/2001/XMLSchema#string

Wenli Feng

http://www.w3.org/2001/XMLSchema#string

Yiru Wang

http://www.w3.org/2001/XMLSchema#string

Zhiqin Xi

http://www.w3.org/2001/XMLSchema#string

Zusha Qiao

http://www.w3.org/2001/XMLSchema#string

P2860

Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors

Antifungal susceptibility testing of Candida species by flow cytometry.

Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.

Emerging fungal diseases.

New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.

Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.

Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates.

Candida krusei: biotechnological potentials and concerns about its safety.

Enhancements and modifications of primer design program Primer3.

P304

938-943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/CJM-2016-0055

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27622981

http://www.w3.org/2001/XMLSchema#string